Vitamins, Minerals and Supplements CDMO Market Size is valued at USD 41.74 Bn in 2024 and is predicted to reach USD 97.60 Bn by the year 2034 at an 9.0% CAGR during the forecast period for 2025-2034.
The Vitamins, Minerals, and Supplements (VMS) Contract Development and Manufacturing Organization (CDMO) market is a rapidly growing segment within the broader nutraceutical industry. VMS CDMOs provide comprehensive services for the development, manufacturing, and packaging of dietary supplements, including vitamins, minerals, and herbal products. These organizations are crucial for helping brands bring innovative formulations to market while ensuring regulatory compliance and maintaining high-quality production processes. VMS supplements are widely used for various health benefits, such as supporting immune function, enhancing physical performance, and promoting overall wellness, catering to diverse consumer needs from general health maintenance to targeted solutions.
A significant driver for the VMS CDMO market is the growing consumer preference for personalized nutrition. As health awareness rises, particularly among millennials and Gen Z, there is an increasing demand for tailored supplement solutions that address individual health needs and lifestyle choices. This trend pushes brands to seek CDMO partners capable of offering innovative formulation capabilities and flexible manufacturing options to meet evolving market demands.
The vitamins, minerals and supplements CDMO market is segmented by types, dosage form, service type, and company size. By type the market is segmented into vitamins, minerals, dietary supplements, others, by dosage form the market is categorized into tablets & capsules, powder, softgel, others. By service type, the market is categorized into product formulation and development, manufacturing and packaging, research & development (R&D), regulatory compliance, and others. By company size the market is categorized into small, mid-sized and large companies.
Softgels are significantly driving the VMS CDMO market due to their consumer popularity for ease of swallowing, pleasant taste, and ability to mask unpleasant flavors. The softgel market is experiencing robust growth, with increasing demand from both consumers and manufacturers, leading brands to rely on CDMOs due to their lack of in-house manufacturing capabilities. CDMOs specializing in softgel production offer valuable expertise in formulation and innovative product development, enhancing efficacy and consumer appeal. Additionally, CDMOs provide the infrastructure and scalability needed to quickly meet rising production demands, allowing brands to enter the market rapidly and efficiently.
Product formulation and development in the VMS CDMO market is expanding due to rising consumer demand for innovative supplement formats, such as gummies and softgels, and the trend towards personalized nutrition that requires custom formulations. This growth is also driven by the need for regulatory compliance and CDMOs' access to advanced ingredients and technologies, which enable brands to create effective and appealing products. As a result, brands increasingly rely on CDMOs to leverage their expertise and resources in developing new and tailored supplement solutions.
The VMS CDMO market is growing in North America due to increased consumer focus on health and wellness, especially for immune support post-COVID-19. This drives demand for innovative products and advanced formulation capabilities from CDMOs. The region's stringent regulatory framework ensures compliance and quality assurance, giving brands confidence in their products. North American CDMOs lead in innovation and R&D, creating effective supplements that meet evolving consumer preferences. Additionally, market consolidation is pushing CDMOs to offer comprehensive, one-stop-shop solutions for formulation, manufacturing, and packaging, streamlining operations and reducing risks for brands.
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 41.74 Bn |
| Revenue Forecast In 2031 | USD 97.60 Bn |
| Growth Rate CAGR | CAGR of 9.0% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Types, Dosage Form, Service Type, Company Size and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; Southeast Asia |
| Competitive Landscape | Aenova Group, Catalent Inc., CAPTEK Softgel International Inc., Health Wright Products, Inc., INPHARMA S.p.A., Lonza, NutraScience Labs, PLT Health Solutions, Robinson Pharma, Inc., SFI Health, Sirio Pharma, Softigel (A division of Procaps Group), Akums Drugs and Pharmaceutical Ltd., Atlantic Essential Products, Inc, B&D Nutritional Ingredients, Gemini Pharmaceuticals, Innovations in Nutrition + Wellness, LiquidCapsule, Martinez Nieto, MediGrün Naturprodukte GmbH (MediGrun), Nutraceuticals International Group, Recipharm AB, Rain Nutrience , Nutrilo GmbH |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Vitamins, Minerals and Supplements CDMO Market by Types -
Vitamins, Minerals and Supplements CDMO Market by Dosage Form -
Vitamins, Minerals and Supplements CDMO Market by Service Type -
Vitamins, Minerals and Supplements CDMO Market by Company size -
Vitamins, Minerals and Supplements CDMO Market by Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.